GHRP-6 Research Hub — GH Release & Appetite Pathway Studies
GHRP-6 is a synthetic hexapeptide ghrelin-receptor agonist studied for both GH-release and orexigenic pathway research. This hub compiles GHRP-6 reference material and family comparisons.
What this hub covers
- GHS-R1a agonism and ghrelin-like appetite signalling
- Acute GH-release dose-response
- Comparisons to GHRP-2, hexarelin and ipamorelin
- GHRH + GHRP synergy in published combination studies
- Reconstitution and storage
GHRP-6 research articles
All research →GHRP-6 Benefits and Side Effects: A Research Guide
Published benefits, side effects, and class comparisons for GHRP-6 — the original ghrelin-mimetic GH secretagogue and foundational reference compound for appetite, cachexia, and GH-pulse research.
Read article →GHRP-2 Benefits and Side Effects: A Research Guide
Published benefits, side effects, and class comparisons for GHRP-2 (pralmorelin) — the clinically validated GH-secretagogue used in diagnostic pituitary-reserve testing and GHRP-class research.
Read article →Hexarelin Benefits and Side Effects: A Research Guide
Published benefits, side effects, and class comparisons for Hexarelin — the high-potency GHRP with dual pituitary GHS-R1a and cardiac CD36 activity that defines its place in growth-hormone secretagogue research.
Read article →Ipamorelin Benefits and Side Effects: A Research Guide
Published benefits, side effects, and GHRP comparisons for ipamorelin — the most receptor-selective GHRP and standard partner for GHRH analogues.
Read article →Related research hubs
Researchers studying GHRP-6 commonly cross-reference these compounds.
CJC-1295 is a tetrasubstituted GHRH(1-29) analog studied in two forms: with a drug-affinity complex (DAC) that binds serum albumin and extends half-life to days, and without DAC (also called Mod GRF 1-29) for short, pulsatile GH stimulation.
Explore hub →Ipamorelin is a pentapeptide growth hormone secretagogue and selective agonist of the ghrelin (GHS-R1a) receptor. It is the most receptor-selective GHRP in the published research, notable for stimulating GH release without significantly elevating cortisol, prolactin or aldosterone.
Explore hub →Hexarelin is a synthetic GH-releasing hexapeptide widely cited in growth-hormone secretagogue and cardiac research models. This hub aggregates Ares Research's reference material on Hexarelin mechanism, dosing literature, and head-to-head comparisons with other GHRPs.
Explore hub →GHRP-6 research FAQ
- What is GHRP-6?
- GHRP-6 is a synthetic hexapeptide ghrelin-receptor agonist studied as a GH secretagogue and in appetite-pathway research.
- How does GHRP-6 differ from GHRP-2?
- GHRP-6 produces more pronounced orexigenic (appetite-stimulating) effects than GHRP-2, while GHRP-2 generates a larger GH response per unit dose.
All content on this hub is provided strictly for laboratory research purposes. Compounds listed are not for human or veterinary consumption. See our research-use disclosure for full terms.